329 related articles for article (PubMed ID: 34951138)
1. Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients.
Ubachs J; van de Worp WRPH; Vaes RDW; Pasmans K; Langen RC; Meex RCR; van Bijnen AAJHM; Lambrechts S; Van Gorp T; Kruitwagen RFPM; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):311-324. PubMed ID: 34951138
[TBL] [Abstract][Full Text] [Related]
2. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
[TBL] [Abstract][Full Text] [Related]
3. Human pancreatic tumour organoid-derived factors enhance myogenic differentiation.
Vaes RDW; van Dijk DPJ; Farshadi EA; Olde Damink SWM; Rensen SS; Langen RC
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1302-1313. PubMed ID: 35146962
[TBL] [Abstract][Full Text] [Related]
4. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
Biolo G; Cederholm T; Muscaritoli M
Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of sarcopenia and cachexia: recent research advances.
Sakuma K; Aoi W; Yamaguchi A
Pflugers Arch; 2017 Jun; 469(5-6):573-591. PubMed ID: 28101649
[TBL] [Abstract][Full Text] [Related]
6. Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
Emami A; Saitoh M; Valentova M; Sandek A; Evertz R; Ebner N; Loncar G; Springer J; Doehner W; Lainscak M; Hasenfuß G; Anker SD; von Haehling S
Eur J Heart Fail; 2018 Nov; 20(11):1580-1587. PubMed ID: 30160804
[TBL] [Abstract][Full Text] [Related]
7. Emerging markers of cancer cachexia and their relationship to sarcopenia.
Lipshitz M; Visser J; Anderson R; Nel DG; Smit T; Steel HC; Rapoport B
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17511-17527. PubMed ID: 37906352
[TBL] [Abstract][Full Text] [Related]
8. 7β-Hydroxycholesterol and 7-ketocholesterol: New oxidative stress biomarkers of sarcopenia inducing cytotoxic effects on myoblasts and myotubes.
Ghzaiel I; Zarrouk A; Pires V; de Barros JP; Hammami S; Ksila M; Hammami M; Ghrairi T; Jouanny P; Vejux A; Lizard G
J Steroid Biochem Mol Biol; 2023 Sep; 232():106345. PubMed ID: 37286110
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive proteome analysis of human skeletal muscle in cachexia and sarcopenia: a pilot study.
Ebhardt HA; Degen S; Tadini V; Schilb A; Johns N; Greig CA; Fearon KCH; Aebersold R; Jacobi C
J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):567-582. PubMed ID: 28296247
[TBL] [Abstract][Full Text] [Related]
10. The complexity of treating wasting in ambulatory rehabilitation: Is it starvation, sarcopenia, cachexia or a combination of these conditions?
Yaxley A; Miller MD; Fraser RJ; Cobiac L; Crotty M
Asia Pac J Clin Nutr; 2012; 21(3):386-93. PubMed ID: 22705428
[TBL] [Abstract][Full Text] [Related]
11. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
12. Differentiating Sarcopenia and Cachexia Among Patients With Cancer.
Peterson SJ; Mozer M
Nutr Clin Pract; 2017 Feb; 32(1):30-39. PubMed ID: 28124947
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass.
Sakuma K; Yamaguchi A
J Cachexia Sarcopenia Muscle; 2012 Jun; 3(2):77-94. PubMed ID: 22476916
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia, cachexia and congestive heart failure in the elderly.
Zamboni M; Rossi AP; Corzato F; Bambace C; Mazzali G; Fantin F
Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):58-67. PubMed ID: 23369138
[TBL] [Abstract][Full Text] [Related]
15. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
[TBL] [Abstract][Full Text] [Related]
16. Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.
Wu KC; Chu PC; Cheng YJ; Li CI; Tian J; Wu HY; Wu SH; Lai YC; Kao HH; Hsu AL; Lin HW; Lin CH
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2073-2087. PubMed ID: 35718751
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact.
Prado CM; Cushen SJ; Orsso CE; Ryan AM
Proc Nutr Soc; 2016 May; 75(2):188-98. PubMed ID: 26743210
[TBL] [Abstract][Full Text] [Related]
18. CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
Khristenko E; Sinitsyn V; Rieden T; Girod P; Kauczor HU; Mayer P; Klauss M; Lyadov V
PLoS One; 2024; 19(1):e0291185. PubMed ID: 38271373
[TBL] [Abstract][Full Text] [Related]
19. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum stress and unfolded protein response profile in quadriceps of sarcopenic patients with respiratory diseases.
Barreiro E; Salazar-Degracia A; Sancho-Muñoz A; Gea J
J Cell Physiol; 2019 Jul; 234(7):11315-11329. PubMed ID: 30565689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
